Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth B. Lee Jr currently holds 68,863 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth B. Lee Jr has been a net buyer of GTHX stock. They have purchased $1.6M and sold $355.8K worth of shares.
Kenneth B. Lee Jr's most recent insider trade was on Jun 13, 2023, when they sold 16,745 shares at $0.00 per share.
Kenneth B. Lee Jr serves as Executive at G1 Therapeutics, Inc. (GTHX). They have executed 82 insider transactions totaling $2.0M over their tenure at the company.
Kenneth B. Lee Jr holds the position of Executive at G1 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Kenneth B. Lee Jr has shown a buying trading pattern, with $1.6M in total purchases and $355.8K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Kenneth B. Lee Jr was on Oct 22, 2018, when they purchased $750.0K worth of PHAS shares. This transaction involved 150,000 shares at $5.00 per share.
Kenneth B. Lee Jr currently owns 68,863 shares of G1 Therapeutics, Inc. (GTHX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth B. Lee Jr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth B. Lee Jr has 82 Form 4 filings on record as an insider at G1 Therapeutics, Inc..
Set alerts for Kenneth B. Lee Jr and 40,000+ other insiders.